Who Owns MeiraGTx Stock?
NASDAQ: MGTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 10:15 AM ET
Ownership breakdown
- Held by institutions
- 70.51%
- Held by insiders
- 16.33%
- Institutional holders
- 222
- Institutions 70.5%
- Insiders 16.3%
- Public and other 13.2%
Who owns MeiraGTx stock?
Institutional investors own about 70.5% of MeiraGTx's shares, spread across 222 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 16.33% of MGTX.
The largest institutional holders are Sanofi (12.70%), Perceptive Advisors Llc (11.23%) and Rubric Capital Management LP (9.47%). Together, the top 10 institutions control 60.6% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their MGTX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MGTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Sanofi | 12.20M | 12.70% | 0.0% |
| Perceptive Advisors Llc | 10.79M | 11.23% | +4.5% |
| Rubric Capital Management LP | 9.10M | 9.47% | +30.0% |
| Johnson & Johnson | 6.64M | 6.91% | 0.0% |
| Blackrock Inc. | 4.76M | 4.95% | +50.2% |
| Adage Capital Partners GP L.L.C. | 4.40M | 4.58% | +10.0% |
| Opaleye Management Inc. | 3.55M | 3.70% | +67.2% |
| Millennium Management Llc | 2.97M | 3.09% | -14.3% |
| 683 Capital Management LLC | 2.30M | 2.39% | -6.1% |
| Woodline Partners LP | 1.50M | 1.56% | +399.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MGTX
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 1.53M | 1.60% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 657.73K | 0.68% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 526.57K | 0.55% |
| iShares Trust-iShares Biotechnology ETF | 522.70K | 0.54% |
| iShares Trust-iShares Russell 2000 Growth ETF | 450.53K | 0.47% |
| Janus Detroit Street Trust-Janus Henderson Small Cap Growth Alpha ETF | 434.67K | 0.45% |
| Janus Detroit Street TRT-Janus Henderson Small/Mid Cap Growth Alpha ET | 313.99K | 0.33% |
| SPDR SERIES TRT-State Street SPDR S&P Kensho New Economies Composite E | 258.14K | 0.27% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 232.10K | 0.24% |
| iShares Trust-iShares Micro-Cap ETF | 204.09K | 0.21% |
Frequently asked questions
Who is the largest shareholder of MeiraGTx?
Sanofi is the largest institutional shareholder of MGTX, owning 12.70% of shares outstanding (12.20M shares) as of its latest 13F filing.
What percentage of MeiraGTx is owned by institutions?
Institutions own about 70.5% of MGTX shares and 84.3% of the public float.
How much of MeiraGTx do insiders own?
Insiders, such as officers and directors, own about 16.33% of MGTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.